Technology | Tumor Tracking Systems | December 02, 2015

Philips Launches IntelliSpace Portal 8.0

Latest edition features full oncology suite, cardiac MR quantification and analysis 

Philips, Intellispace Portal 8.0, oncology suite, EASL, RSNA 2015

December 2, 2015 — Philips announced IntelliSpace Portal 8.0, the latest edition of its advanced data sharing, analytics and visualization platform that helps radiologists detect, diagnose and follow up on treatment of diseases. Introduced at the 2015 Radiological Society of North America Annual Meeting (RSNA) in Chicago, IntelliSpace Portal 8.0 helps address the changing demands in radiology that result from an increasing prevalence of cancer and its economic toll. It delivers new applications – like fast 3-D quantitative renderings of tumors – in a fully integrated oncology suite to improve diagnostic confidence and patient care.

The portal helps clinicians visualize, diagnose, measure disease states and communicate across modalities, with one efficient, automated and guided workflow. The latest release now features more than 68 clinical applications for seven modalities including computed tomography (CT), magnetic resonance (MR), ultrasound, mammography and interventional X-ray (iXR).

A key but challenging clinical need for today’s radiologists is determining how tumors are reacting to new local image-guided treatment approaches, such as tumor ablation and chemoembolization. Currently, this is done by evaluating one- or two-dimensional MRI images taken after the procedure, which give only limited insight and no quantified information. With the growing interest in finding new 3-D quantification options, IntelliSpace Portal 8.0 now includes, as an option for qualified researchers, qEASL, a quantitative technology which can be used in conjunction with its Multi-Modality Tumor Tracking (MMTT) application. With this technology, researchers can make a specialized analysis of 3-D imaging scans (e.g. CT and MRI) with the aim to enhance measurement of living and dying tumor tissue by giving them a visual indication of how cells respond to therapy. qEASL has been developed in close collaboration with leading clinical scientists at Yale School of Medicine and aims to improve the current standard for cancer treatment follow-ups as defined by the European Association for the Study of the Liver (EASL).

“Image-guided local tumor therapies are very difficult to evaluate for effectiveness, and traditional methods lack reproducibility and involve some level of guesswork,” said Jean-Francois (Jeff) Geschwind, M.D., chairman, Department of Radiology and Biomedical Imaging at Yale School of Medicine. “Redefining and standardizing how we assess this kind of treatment is revolutionary for radiology and the kind of care we can deliver for patients.”

IntelliSpace Portal 8.0 features enhanced capabilities and enriched clinical decision support:

  • With the increasing interest in pulmonary care, IntelliSpace Portal 8.0 now includes the new CT Lung Nodule Assessment (LNA) application designed for a more efficient and longitudinal workflow, which features a risk assessment tool for clinical decision support;
  • Through the Lung Nodule CAD, radiologists also have access to the computer-aided detection system for chest multi-slice CT exams;
  • A complete pulmonary solution, IntelliSpace Portal 8.0 also includes applications to aid clinicians in measuring and tracking chronic obstructive pulmonary disease (COPD), detecting pulmonary emboli and performing calcium scoring;
  • Embedded in the entire cardiac workflow, the MR Cardiac Quantitative Mapping enables fast quantification and analysis workflow for T1, T2 and T2 generated maps to enhance the diagnostic view in cardiomyopathies (disease of the heart muscle);
  • Enhanced capabilities in the Multi-Modality Viewer allow for the review, editing and analysis of Philips iXR and general radiology datasets. MR Smart Display Protocols deliver the best-fitting display protocols for each individual patient based on the radiologist’s preferred initial viewing layouts; and
  • The advanced capabilities of IntelliSpace Portal 8.0 will also assist in complying with Meaningful Use legislation in the United States by empowering radiologists to update electronic medical records (EMRs) easily and share patient information with various organizations such as public health agencies and specialized registries. With enhanced reporting features, radiologists can augment clinical reports with exportable graphs and tables, which can be collated into a single patient report and stored directly on the picture archiving and communication system (PACS) or radiology information system (RIS).

Philips hosted a special event during RSNA highlighting the MMTT qEASL concept, featuring Philips physician partners from Yale University, Charité Berlin and MD Anderson discussing volumetric measurements as a concept for response assessment in cancer treatment.

For more information: www.philips.com

Related Content

myExam Companion user interface on both systems helps technologists of every experience level achieve consistently high image quality
News | Digital Radiography (DR) | January 25, 2021
January 25, 2021 — Siemens Healthineers has announced the Food and Drug Administration (FDA) clearance of the...
The key trends Clinicians reviewing a COVID-19 patient's lung CT that reveals the severity of COVID-caused pneumonia. The impact of COVID on radiology was a major, over arching trend at  the 2020 Radiological Society of North America (RSNA) meeting. Getty Imagesbserved at 2020 Radiological Society of North America (RSNA) meeting all focused around COVID-19 (SARS-CoV-2) and the impact it has had on radiology. #RSNA #RSNA20 #RSNA2020

Clinicians reviewing a COVID-19 patient's lung CT that reveals the severity of COVID-caused pneumonia. The impact of COVID on radiology was a major, over arching trend at  the 2020 Radiological Society of North America (RSNA) meeting. Getty Images

Feature | RSNA | January 20, 2021 | By Melinda Taschetta-Millane and Dave Fornell
MRI Targeted biopsy is performed using cognitive fusion more easily with anatomical guidance based on the radiology report. MRI targets can be identified quickly in real-time along with micro-ultrasound targets, which may have been missed on MRI.

MRI Targeted biopsy is performed using cognitive fusion more easily with anatomical guidance based on the radiology report. MRI targets can be identified quickly in real-time along with micro-ultrasound targets, which may have been missed on MRI. Image courtesy of Exact Imaging

Feature | Prostate Cancer | January 20, 2021 | By Brian Wodlinger, Ph.D.
Historically when a patient had an elevated PSA (prostate specific antigen) test their urologist would take the next
According to a new research report1 on the contrast media injectors published by MarketsandMarkets, the market was estimated to be $1.3 billion in 2020 and projected to reach $1.9 billion by 2025, at a compound annual growth rate (CAGR) of 7.4 percent over 2020-2025.

The ulrich CTmotion

Feature | Contrast Media Injectors | January 20, 2021 | By Melinda Taschetta-Millane
According to a new...
The exceptionally high dose rate of the FLASH Beam is 3,000 times higher than normal therapy treatment (300 Gray per second vs. 0.1 Gray per second, Gray being a standard unit measuring absorbed radiation). Instead of treatment over 20 seconds, an entire treatment is completed in 6 milliseconds, giving the therapy its nickname, "FLASH." Image courtesy of Brian Pogue, PhD

The exceptionally high dose rate of the FLASH Beam is 3,000 times higher than normal therapy treatment (300 Gray per second vs. 0.1 Gray per second, Gray being a standard unit measuring absorbed radiation). Instead of treatment over 20 seconds, an entire treatment is completed in 6 milliseconds, giving the therapy its nickname, "FLASH." Image courtesy of Brian Pogue, PhD

News | Linear Accelerators | January 20, 2021
January 20, 2021 — A joint team of researchers from Radiation Oncology at Dartmouth's and...
More complex, longer interventional procedures such as structural heart interventions or this revascularization of a coronary chronic total occlusion (CTO) at Henry Ford Hospital in Detroit, requires angiography imaging systems that have improved image detail and lower radiation dose. However, purchase of new systems was put on hold by many hospitals in 2020 due to the sudden drop in elective procedures and diversion of resources due to the COVID-19. Photo by Dave Fornell.

More complex, longer interventional procedures such as structural heart interventions or this revascularization of a coronary chronic total occlusion (CTO) at Henry Ford Hospital in Detroit, requires angiography imaging systems that have improved image detail and lower radiation dose. However, purchase of new systems was put on hold by many hospitals in 2020 due to the sudden drop in elective procedures and diversion of resources due to the COVID-19. Photo by Dave Fornell.

Feature | Angiography | January 19, 2021 | By Bhvita Jani
January 19, 2021 – With the postponement of non-essential elective surgeries and medical procedures in 2020 to conser
Novel Coronavirus SARS-CoV-2 Transmission electron micrograph of SARS-CoV-2 virus particles, isolated from a patient. Image captured and color-enhanced at the NIAID Integrated Research Facility (IRF) in Fort Detrick, Maryland. Credit: National Institute of Allergy and Infectious Diseases, NIH

Novel Coronavirus SARS-CoV-2 Transmission electron micrograph of SARS-CoV-2 virus particles, isolated from a patient. Image captured and color-enhanced at the NIAID Integrated Research Facility (IRF) in Fort Detrick, Maryland. Image courtesy of  National Institute of Allergy and Infectious Diseases (NIH)

News | Coronavirus (COVID-19) | January 15, 2021
January 15, 2021 — In one of the first studies to examine the impact of the...